There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination

References

• Cervical Cancer Action. Global maps: global progress in HPV vaccination: status: June 2017. Published 2017. [Accessed Jan 2019 3]. http://www.cervicalcanceraction.org/comments/comments3.php
   Google Scholar
• Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571. doi:10.1016/S0140-6736(15)61152-7.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years – United States, 2017. MMWR Morbidity Mortality Weekly Rep. 2018;67(33):909–17. doi:10.15585/mmwr.mm6733a1.
   PubMed Web of Science ®Google Scholar
• Statens Serum Institut. Twice as many received HPV vaccination in 2017 as in 2016. 2018 [Accessed 2019 Mar 15]. https://en.ssi.dk/news/news/2018/2018—01—hpv
   Google Scholar
• Health Service Executive. HSE confirms HPV vaccine uptake is now 70%. 2019. [Accessed 2019 Mar 14]. https://www.hse.ie/eng/services/news/media/pressrel/hse-confirms-hpv-vaccine-uptake-is-now-70-.html.
   Google Scholar
• Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7–8):1533–1540. doi:10.1080/21645515.2019.1611157.
   Web of Science ®Google Scholar
• Brotherton JM. Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule. Aust J Gen Pract. 2018;47:417–21.
   PubMed Web of Science ®Google Scholar
• England PH. Human papillomavirus (HPV) vaccine coverage in England, 2008/09 to 2013/14: a review of the full six years of the three-dose schedule. London (England): Public Health England; 2015.
   Google Scholar
• Torres-Rueda S, Rulisa S, Burchett HE, Mivumbi NV, Mounier-Jack S. HPV vaccine introduction in Rwanda: impacts on the broader health system. Sex Reprod Healthc. 2016;7:46–51. doi:10.1016/j.srhc.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Muhamad NA, Buang SN, Jaafar S, Jais R, Tan PS, Mustapha N, Lodz NA, Aris T, Sulaiman LH, Murad S. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme. BMC Public Health. 2018;18(1):1402. doi:10.1186/s12889-018-6316-6.
   PubMed Web of Science ®Google Scholar
• Perez S, Zimet GD, Tatar O, Stupiansky NW, Fisher WA, Rosberger Z. Human papillomavirus vaccines: successes and future challenges. Drugs. 2018;78(14):1385–96. doi:10.1007/s40265-018-0975-6.
   PubMed Web of Science ®Google Scholar
• Head KJ, Biederman E, Sturm LA, Zimet GD. A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States. Hum Vaccin Immunother. 2018;14(7). doi:10.1080/21645515.2018.1486156.
   PubMed Web of Science ®Google Scholar
• Hoffman BL, Felter EM, Chu K-H, Shensa A, Hermann C, Wolynn T, Williams D, Primack BA. It’s not all about autism: the emerging landscape of anti-vaccination sentiment on Facebook. Vaccine. 2019;37(16):2216–23. doi:10.1016/j.vaccine.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Ortiz RR, Smith A, Coyne-Beasley T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum Vaccin Immunother. 2019;15(7–8):1465–1475. doi:10.1080/21645515.2019.1581543.
   PubMed Web of Science ®Google Scholar
• Basch C, MacLean SBA. A content analysis of HPV related posts on instagram. Hum Vaccin Immunother. 2019;15(7–8):1476–1478.
   PubMed Web of Science ®Google Scholar
• Buller DB, Walkosz BJ, Berteletti J, Pagoto SL, Bibeau J, Baker K, Hillhouse J, Henry KL. Insights on HPV vaccination in the United States from mothers’ comments on Facebook posts in a randomized trial. Hum Vaccin Immunother. 2019;15(7–8):1479–1487. doi:10.1080/21645515.2019.1581555.
   PubMed Web of Science ®Google Scholar
• Dyda A, Shah Z, Surian D, Martin P, Coiera E, Dey A, Leask J, Dunn AG. HPV vaccine coverage in Australia and associations with HPV vaccine information exposure among Australian Twitter users. Hum Vaccin Immunother. 2019;15(7–8):1488–1495. doi:10.1080/21645515.2019.1596712.
   PubMed Web of Science ®Google Scholar
• Luo X, Zimet G, Shah S. A natural language processing framework to analyse the opinions on HPV vaccination reflected in Twitter over 10 years (2008–2017). Hum Vaccin Immunother. 2019;15(7–8):1496–1504. doi:10.1080/21645515.2019.1627821.
   Web of Science ®Google Scholar
• MacLean SA, Basch CH, Ethan D, Garcia P. Readability of online information about HPV Immunization. Hum Vaccin Immunother. 2019;15(7–8):1505–1507.
   PubMed Web of Science ®Google Scholar
• Rosen BL, Bishop JM, Anderson R, Real FJ, Klein MD, Kreps GL. A content analysis of HPV vaccine online continuing medical education purpose statements and learning objectives. Hum Vaccin Immunother. 2019;15(7–8):1508–1518. doi:10.1080/21645515.2019.1587273.
   Web of Science ®Google Scholar
• Hoss A, Meyerson BE, Zimet GD. State statutes and regulations related to human papillomavirus vaccination. Hum Vaccin Immunother. 2019;15(7–8):1519–1526. doi:10.1080/21645515.2019.1627817.
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccin Immunother. 2019;15(7–8):1527–1532. doi:10.1080/21645515.2018.1553475.
   PubMed Web of Science ®Google Scholar
• Forster AS, Gilson R. Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men. Hum Vaccin Immunother. 2019;15(7–8):1541–1543.
   PubMed Web of Science ®Google Scholar
• Schim van der Loeff MF, Vorsters A, Marra E, Van Damme P, Hogewoning A. Should female sex workers be offered HPV vaccination? Hum Vaccin Immunother. 2019;15(7–8):1544–1548. doi:10.1080/21645515.2019.1602432.
   Web of Science ®Google Scholar
• Stephens A, Wynn C, Stockwell M. Understanding the use of digital technology to promote human papillomavirus vaccination – a RE-AIM framework approach. Hum Vaccin Immunother. 2019;15(7–8):1549–1561. doi:10.1080/21645515.2019.1611158.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Rupp R, Dinehart EE, Cofie LE, Kuo YF, Hirth JM. Achieving high HPV vaccine completion rates in a pediatric clinic population. Hum Vaccin Immunother. 2019;15(7–8):1562–1569.
   PubMed Web of Science ®Google Scholar
• Bonville CA, Domachowske JB, Suryadevara M. A quality improvement education initiative to increase adolescent human papillomavirus (HPV) vaccine completion rates. Hum Vaccin Immunother. 2019;15(7–8):1570–1576. doi:10.1080/21645515.2019.1627822.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Maertens J, Sevick C, Jimenez-Zambrano A, Juarez-Colunga E. A randomized, controlled, pragmatic trial of an iPad-based, tailored messaging intervention to increase human papillomavirus vaccination among Latinos. Hum Vaccin Immunother. 2019;15(7–8):1577–1584. doi:10.1080/21645515.2018.1559685.
   PubMed Web of Science ®Google Scholar
• Hirth JM, Berenson AB, Cofie LE, Matsushita L, Kuo YF, Rupp RE. Caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics: a qualitative program evaluation. Hum Vaccin Immunother. 2019;15(7–8):1585–1591. doi:10.1080/21645515.2019.1587276.
   Web of Science ®Google Scholar
• Reno JE, Thomas J, Pyrzanowski J, et al. Examining strategies for improving healthcare providers’ communication about adolescent HPV vaccination: evaluation of secondary outcomes in a randomized controlled trial. Hum Vaccin Immunother. 2019;15(7–8):1592–1598.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Pyrznawoski J, Lockhart S, Page S, Sibley L, Skinner A. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):732–40. doi:10.1001/jamapediatrics.2018.1273.
   PubMed Web of Science ®Google Scholar
• Brandt HM, Vanderpool RC, Curry SJ, Farris P, Daniel-Ulloa J, Seegmiller L, Stradtman LR, Vu T, Taylor V, Zubizarreta M. A multi-site case study of community-clinical linkages for promoting HPV vaccination. Hum Vaccin Immunother. 2019;15(7–8):1599–1606. doi:10.1080/21645515.2019.1616501.
   PubMed Web of Science ®Google Scholar
• Gualano MR, Thomas R, Stillo M, et al. What is the most useful tool in HPV vaccine promotion? Results from an experimental study. Hum Vaccin Immunother. 2019;15(7–8):1607–1614.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019;15(7–8):1615–1627. doi:10.1080/21645515.2018.1564436.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA. Addressing HPV vaccine myths: practical information for healthcare providers. Hum Vaccin Immunother. 2019;15(7–8):1628–1638. doi:10.1080/21645515.2019.1565267.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Fisher-Borne M, Brewer NT. Engaging parents around vaccine confidence: proceedings from the national HPV vaccination roundtable meetings. Hum Vaccin Immunother. 2019;15(7–8):1639–1640.
   PubMed Web of Science ®Google Scholar
• Baldovin T, Bertoncello C, Cocchio S, Fonzo M, Gazzani D, Buja A, Majori S, Baldo V. Perception and knowledge of HPV-related and vaccine-related conditions among a large cohort of university students in Italy. Hum Vaccin Immunother. 2019;15(7–8):1641–1649. doi:10.1080/21645515.2018.1564432.
   PubMed Web of Science ®Google Scholar
• Dube E, Gagnon D, Clement P, Bettinger JA, Comeau JL, Deeks S, Guay M, MacDonald S, MacDonald NE, Mijovic H, et al. Challenges and opportunities of school-based HPV vaccination in Canada. Hum Vaccin Immunother. 2019;15(7–8):1650–1655. doi:10.1080/21645515.2018.1564440.
   PubMed Web of Science ®Google Scholar
• Shetty S, Prabhu S, Shetty V, Shetty AK. Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India. Hum Vaccin Immunother. 2019;15(7–8):1656–1665. doi:10.1080/21645515.2019.1565260.
   PubMed Web of Science ®Google Scholar
• Thomas TL, Caldera M, Maurer J. A short report: parents HPV vaccine knowledge in rural South Florida. Hum Vaccin Immunother. 2019;15(7–8):1666–1671. doi:10.1080/21645515.2019.1600986.
   PubMed Web of Science ®Google Scholar
• Topazian HM, Dizon AM, Di Bona VL, Levitz L, Ramos S, Morgan K, Kim CJ, Richter K, De Sanjose S, Smith JS. Adolescent providers’ knowledge of human papillomavirus vaccination age guidelines in five countries. Hum Vaccin Immunother. 2019;15(7–8):1672–1677. doi:10.1080/21645515.2018.1558688.
   PubMed Web of Science ®Google Scholar
• Victory M, Do TQN, Kuo YF, Rodriguez AM. Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas. Hum Vaccin Immunother. 2019;15(7–8):1678–1687. doi:10.1080/21645515.2019.1628551.
   PubMed Web of Science ®Google Scholar
• Zhou M, Qu S, Zhao L, Campy KS, Wang S. Parental perceptions of human papillomavirus vaccination in central China: the moderating role of socioeconomic factors. Hum Vaccin Immunother. 2019;15(7–8):1688–1696.
   Web of Science ®Google Scholar
• Rubens-Augustson T, Wilson LA, Murphy MS, et al. Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study. Hum Vaccin Immunother. 2019;15(7–8):1697–1707.
   PubMed Web of Science ®Google Scholar
• Panozzo C, Gilkey MBP, Kornides MLS, Wharam JF. Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan. Hum Vaccin Immunother. 2019;15(7–8):1708–1714. doi:10.1080/21645515.2019.1574150.
   PubMed Web of Science ®Google Scholar
• Fu LY, Haimowitz R, Thompson D. Community members trusted by African American parents for vaccine advice. Hum Vaccin Immunother. 2019;15(7–8):1715–1722. doi:10.1080/21645515.2019.1581553.
   PubMed Web of Science ®Google Scholar
• Nan X, Daily K, Richards A, et al. The role of trust in health information from medical authorities in accepting the HPV vaccine among African American parents. Hum Vaccin Immunother. 2019;15(7–8):1723–1731.
   PubMed Web of Science ®Google Scholar
• Thomas R, Dillard M, Xu J, Zimet GD, Kahn JA. Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women. Hum Vaccin Immunother. 2019;15(7–8):1732–1736. doi:10.1080/21645515.2019.1582401.
   PubMed Web of Science ®Google Scholar
• Wu T, Qu S, Fang Y, Ip M, Wang Z. Behavioral intention to perform risk compensation behaviors after receiving HPV vaccination among men who have sex with men in China. Hum Vaccin Immunother. 2019;15(7–8):1737–1744. doi:10.1080/21645515.2019.1622975.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Mohan D, Janssen EM, McRee AL, Kornides ML, Bridges JFP. Exploring variation in parental worries about HPV vaccination: a latent-class analysis. Hum Vaccin Immunother. 2019;15(7–8):1745–1751. doi:10.1080/21645515.2019.1574157.
   PubMed Web of Science ®Google Scholar
• Herman R, McNutt LA, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019;15(7–8):1752–1759. doi:10.1080/21645515.2019.1571891.
   PubMed Web of Science ®Google Scholar
• Kellogg C, Shu J, Arroyo A, Dinh NT, Wade N, Sanchez E, Equils O. A significant portion of college students are not aware of HPV disease and HPV vaccine recommendations. Hum Vaccin Immunother. 2019;15(7–8):1760–1766. doi:10.1080/21645515.2019.1627819.
   PubMed Web of Science ®Google Scholar
• Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka D. HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Hum Vaccin Immunother. 2019;15(7–8):1767–1775. doi:10.1080/21645515.2019.1619407.
   PubMed Web of Science ®Google Scholar
• Hopfer S, Wright ME, Pellman H, Wasserman R, Fiks AG. HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance. Hum Vaccin Immunother. 2019;15(7–8):1776–1783.
   PubMed Web of Science ®Google Scholar
• Lake PW, Kasting ML, Christy SM, Vadaparampil ST. Provider perspectives on multilevel barriers to HPV vaccination. Hum Vaccin Immunother. 2019;15(7–8):1784–1793. doi:10.1080/21645515.2019.1581554.
   PubMed Web of Science ®Google Scholar
• Grandahl M, Neveus T, Dalianis T, Larsson M, Tyden T, Stenhammar C. ‘I also want to be vaccinated!’ – adolescent boys’ awareness and thoughts, perceived benefits, information sources, and intention to be vaccinated against human papillomavirus (HPV). Hum Vaccin Immunother. 2019;15(7–8):1794–1802.
   PubMed Web of Science ®Google Scholar
• Tatar O, Shapiro GK, Perez S, Wade K, Rosberger Z. Using the precaution adoption process model to clarify human papillomavirus vaccine hesitancy in canadian parents of girls and parents of boys. Hum Vaccin Immunother. 2019;15(7–8):1803–1814. doi:10.1080/21645515.2019.1575711.
   PubMed Web of Science ®Google Scholar
• Fontenot HB, Rosenberger JG, McNair KT, Mayer KH, Zimet G. Perspectives and preferences for a mobile health tool designed to facilitate HPV vaccination among young men who have sex with men. Hum Vaccin Immunother. 2019;15(7–8):1815–1823. doi:10.1080/21645515.2019.1568156.
   PubMed Web of Science ®Google Scholar
• Kornides M, Head KJ, Feemster K, Zimet GD, Panozzo CA. Associations between HPV vaccination among women and their 11–14 year-old children. Hum Vaccin Immunother. 2019;15(7–8):1824–1830.
   Web of Science ®Google Scholar
• Calo WA, Shah PD, Gilkey MB, Vanderpool RC, Barden S, Doucette WR, Brewer NT. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states. Hum Vaccin Immunother. 2019;15(7–8):1831–1838. doi:10.1080/21645515.2019.1602433.
   PubMed Web of Science ®Google Scholar
• Islam JY, Gruber JF, Kepka D, et al. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States. Hum Vaccin Immunother. 2019;15(7–8):1839–1850.
   PubMed Web of Science ®Google Scholar
• Elsamadicy EA, Schneiter MK, Hull PC, Khabele D. Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review. Hum Vaccin Immunother. 2019;15(7–8):1851–1855. doi:10.1080/21645515.2019.1619405.
   PubMed Web of Science ®Google Scholar
• Griner SB, Thompson EL, Vamos CA, Chaturvedi AK, Vazquez-Otero C, Merrell LK, Kline NS, Daley EM. Dental opinion leaders’ perspectives on barriers and facilitators to HPV-related prevention. Hum Vaccin Immunother. 2019;15(7–8):1856–1862. doi:10.1080/21645515.2019.1565261.
   PubMed Web of Science ®Google Scholar
• Walker KK, Jackson RD, Sommariva S, Neelamegam M, Desch J. USA dental health providers’ role in HPV vaccine communication and HPV-OPC protection: a systematic review. Hum Vaccin Immunother. 2019;15(7–8):1863–1869. doi:10.1080/21645515.2018.1558690.
   PubMed Web of Science ®Google Scholar
• Oliver K, McCorkell C, Pister I, Majid N, Benkel DH, Zucker JR. Improving HPV vaccine delivery at school-based health centers. Hum Vaccin Immunother. 2019;15(7–8):1870–1877. doi:10.1080/21645515.2019.1578596.
   PubMed Web of Science ®Google Scholar
• Nobel T, Rajupet S, Sigel K, Oliver K. Using Veterans Affairs Medical Center (VAMC) data to identify missed opportunities for HPV vaccination. Hum Vaccin Immunother. 2019;15(7–8):1878–1883. doi:10.1080/21645515.2018.1559684.
   PubMed Web of Science ®Google Scholar
• Geng Y, Liu L. Human papillomavirus genotypes and infection among women in Changzhou, China. Hum Vaccin Immunother. 2019;15(7–8):1884–1888. doi:10.1080/21645515.2019.1611159.
   PubMed Web of Science ®Google Scholar
• Wang J, Tang D, Wang J, Zhang Z, Chen Y, Wang K, Zhang X, Ma C. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China. Hum Vaccin Immunother. 2019;15(7–8):1889–1896. doi:10.1080/21645515.2019.1578598.
   PubMed Web of Science ®Google Scholar
• Bhattacharya M, Reiter PL, McRee AL. Nativity status and genital HPV infection among adults in the U.S. Hum Vaccin Immunother. 2019;15(7–8):1897–1903. doi:10.1080/21645515.2019.1578592.
   PubMed Web of Science ®Google Scholar
• Orlando G, Frati ER, Fasolo MM, et al. Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS. Hum Vaccin Immunother. 2019;15(7–8):1904–1910.
   PubMed Web of Science ®Google Scholar
• Nyitray AG, Peng F, Day RS, Carvalho Da Silva RJ, Baggio ML, Salmerón J, Quiterio M, Abrahamsen M, Lazcano-Ponce E, Villa LL, et al. The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study. Hum Vaccin Immunother. 2019;15(7–8):1911–1919. doi:10.1080/21645515.2019.1593083.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Simpson MC, Massa ST, Adjei Boakye E, Antisdel JL, Varvares MA. 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States. Oral Oncol. 2017;74:90–97. doi:10.1016/j.oraloncology.2017.09.015.
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329. doi:10.1371/journal.pone.0068329.
   PubMed Web of Science ®Google Scholar
• Hirth JM, Chang M, Resto VA. Prevalence of oral human papillomavirus by vaccination status among young adults (18–30years old). Vaccine. 2017;35(27):3446–51. doi:10.1016/j.vaccine.2017.05.025.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Gillison ML. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36:262–67. doi:10.1200/JCO.2017.75.0141.
   PubMed Web of Science ®Google Scholar
• Timbang MR, Sim MW, Bewley AF, Farwell DG, Mantravadi A, Moore MG. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection. Hum Vaccin Immunother. 2019;15(7–8):1920–1928. doi:10.1080/21645515.2019.1600985.
   PubMed Web of Science ®Google Scholar
• Shew M, Shew ML, Bur AM. Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer. Hum Vaccin Immunother. 2019;15(7–8):1929–1934.
   PubMed Web of Science ®Google Scholar
• Windon MJ, Waterboer T, Hillel AT, Chien W, Best S, Stewart C, Akst L, Troy T, Bender N, Miles B, et al. Sex differences in HPV immunity among adults without cancer. Hum Vaccin Immunother. 2019;15(7–8):1935–1941. doi:10.1080/21645515.2019.1568157.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Meites E, Ekwueme DU, Saraiya M, Markowitz LE. Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States. Hum Vaccin Immunother. 2019;15(7–8):1942–1948. doi:10.1080/21645515.2019.1603562.
   PubMed Web of Science ®Google Scholar
• De La Fuente J, Hernandez Aguado JJ, Martin MS, Boix PR, Gomez SC, Lopez N. Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain. Hum Vaccin Immunother. 2019;15(7–8):1949–1961. doi:10.1080/21645515.2018.1560770.
   PubMed Web of Science ®Google Scholar
• Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Hum Vaccin Immunother. 2019;15(7–8):1962–1969. doi:10.1080/21645515.2018.1564438.
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Huang L-M, Valencia A, Panzer F, Chiu C-H, Decreux A, Poncelet S, Karkada N, Folschweiller N, Cresens LL, et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10–14 years. Hum Vaccin Immunother. 2019;15(7–8):1970–1979. doi:10.1080/21645515.2019.1625644.
   Web of Science ®Google Scholar
• Gilca V, Sauvageau C, Panicker G, De Serres G, Schiller J, Ouakki M, Unger ER. Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials. Hum Vaccin Immunother. 2019;15(7–8):1980–1985. doi:10.1080/21645515.2019.1605278.
   PubMed Web of Science ®Google Scholar
• Leon-Maldonado L, Cabral A, Brown B, Ryan GW, Maldonado A, Salmerón J, Allen-Leigh B, Lazcano-Ponce E. Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan study experience. Hum Vaccin Immunother. 2019;15(7–8):1986–1994. doi:10.1080/21645515.2019.1619401.
   PubMed Web of Science ®Google Scholar
• Kunda NK, Peabody J, Zhai L, Price DN, Chackerian B, Tumban E, Muttil P. Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil(R) 9. Hum Vaccin Immunother. 2019;15(7–8):1995–2002. doi:10.1080/21645515.2019.1593727.
   PubMed Web of Science ®Google Scholar